26th November 2021
Following the detection of the variant B.1.1.529, we have performed a detailed analysis to fully assess the reliability of our existing tests
8th November 2021
QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech.
16th August 2021
QuantuMDx is partnering with Cignpost Diagnostics, a leading provider of COVID-19 workplace testing to the film & TV industry.
12th August 2021
At ECCMID 2021 last month, our assay team presented three e-posters which focused on our innovative CAPTURE-XT® technology, SARS-CoV-2 RT-PCR Detection Assay and associated…
20th July 2021
Meet Diran Guiliguian, Chief Commercial Officer at QuantuMDx. Tell us about QuantuMDx and your role? QuantuMDx is an innovative company that has…
19th July 2021
Q-POC™ offers a rapid PCR point of care testing solution for COVID-19 across a wide range of settings. Our infographic shows how Q-POC™…
9th July 2021
NEWCASTLE UPON TYNE, UK: QuantuMDx today announces the launch of Q-POC™ – a rapid, PCR point of care diagnostic system. Launching at…
8th June 2021
QuantuMDx has been included in two agreements under PHE’s Microbiology Framework: Diagnostic Goods & Services and Research & Development Goods
26th May 2021
QuantuMDx has appointed Mirre de Noo, as a Non-Executive Director.
12th May 2021
We’re looking for an enthusiastic Microbiology Laboratory Technician to assist the Laboratory Manager and Assay Feasibility Team Lead with running QuantuMDx’s Microbiology facility and other…